2018 - The Foxo1-Inducible Transcriptional Repressor Zfp125 Causes Hepatic Steatosis and Hypercholesterolemia

cell reports 2018

Authors: Gustavo W. Fernandes, Barbara M. L. C. Bocco, Tatiana L. Fonseca, Elizabeth A. McAninch, Sungro Jo, Lattoya J. Lartey, InSug O-Sullivan, Terry G. Unterman, Nailliw Z. Preite, Robin M. Voigt, Christopher B. Forsyth, Ali Keshavarzian, Richárd Sinkó, Allison B. Goldfine, Mary E. Patti, Miriam O. Ribeiro, Balázs Gereben, Antonio C. Bianco.

Abstract

Liver-specific disruption of the type 2 deiodinase gene (Alb-D2KO) results in resistance to both diet-induced obesity and liver steatosis in mice. Here, we report that this is explained by an ∼60% reduction in liver zinc-finger protein-125 (Zfp125) expression. Zfp125 is a Foxo1-inducible transcriptional repressor that causes lipid accumulation in the AML12 mouse hepatic cell line and liver steatosis in mice by reducing liver secretion of triglycerides and hepatocyte efflux of cholesterol. Zfp125 acts by repressing 18 genes involved in lipoprotein structure, lipid binding, and transport. The ApoE promoter contains a functional Zfp125-binding element that is also present in 17 other lipid-related genes repressed by Zfp125. While liver-specific knockdown of Zfp125 causes an “Alb-D2KO-like” metabolic phenotype, liver-specific normalization of Zfp125 expression in Alb-D2KO mice rescues the phenotype, restoring normal susceptibility to diet-induced obesity, liver steatosis, and hypercholesterolemia.

DOI: https://doi.org/10.1016/j.celrep.2017.12.053

 

Artigos Relacionados - Artigos Científicos

© 2013 - 2021 Universidade Federal de São Paulo - Unifesp

Rua Pedro de Toledo, 720, 2º andar - Vila Clementino  •  CEP 04039-002 - São Paulo - SP
+55 11 5576-4848 Ramal 3027 / +55 11 5576-4228 / +55 11 5549-6441  •  ppg.medicinatranslacional@unifesp.br